{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:07:07Z","timestamp":1764842827066},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1693","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>Atrial fibrillation (AF) is the most common arrhythmia in the world. Risk factor modification, anticoagulation, rhythm control, and rate control are the four pillars of its management. American College of Cardiology\/American Heart Association (ACC\/AHA) guidelines on management of AF were updated recently.<\/jats:p>","DOI":"10.58347\/tml.2024.1693a","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:14:47Z","timestamp":1704824087000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Atrial Fibrillation"],"prefix":"10.58347","volume":"66","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2024,1,8]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:14:47Z","timestamp":1704824087000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1693a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":0,"journal-issue":{"issue":"1693","published-online":{"date-parts":[[2024,1,8]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2024.1693a","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}